A citation-based method for searching scientific literature

Suzanne Carreira, Jane Goodall, Laurence Denat, Mercedes Rodriguez, Paolo Nuciforo, Keith S Hoek, Alessandro Testori, Lionel Larue, Colin R Goding. Genes Dev 2006
Times Cited: 400







List of co-cited articles
1131 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiangju Kong, Patricia A Possik, Paulien D M Cornelissen-Steijger, Marnix H Geukes Foppen,[...]. Nat Commun 2014
353
34

In vivo switching of human melanoma cells between proliferative and invasive states.
Keith S Hoek, Ossia M Eichhoff, Natalie C Schlegel, Udo Döbbeling, Nikita Kobert, Leo Schaerer, Silvio Hemmi, Reinhard Dummer. Cancer Res 2008
443
33

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Levi A Garraway, Hans R Widlund, Mark A Rubin, Gad Getz, Aaron J Berger, Sridhar Ramaswamy, Rameen Beroukhim, Danny A Milner, Scott R Granter, Jinyan Du,[...]. Nature 2005
32

Cancer stem cells versus phenotype-switching in melanoma.
Keith S Hoek, Colin R Goding. Pigment Cell Melanoma Res 2010
321
29

Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.
Annelien Verfaillie, Hana Imrichova, Zeynep Kalender Atak, Michael Dewaele, Florian Rambow, Gert Hulselmans, Valerie Christiaens, Dmitry Svetlichnyy, Flavie Luciani, Laura Van den Mooter,[...]. Nat Commun 2015
225
27

MITF-the first 25 years.
Colin R Goding, Heinz Arnheiter. Genes Dev 2019
119
27

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
David J Konieczkowski, Cory M Johannessen, Omar Abudayyeh, Jong Wook Kim, Zachary A Cooper, Adriano Piris, Dennie T Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq,[...]. Cancer Discov 2014
318
24

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.
Itay Tirosh, Benjamin Izar, Sanjay M Prakadan, Marc H Wadsworth, Daniel Treacy, John J Trombetta, Asaf Rotem, Christopher Rodman, Christine Lian, George Murphy,[...]. Science 2016
24

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Y Cheli, S Giuliano, N Fenouille, M Allegra, V Hofman, P Hofman, P Bahadoran, J-P Lacour, S Tartare-Deckert, C Bertolotto,[...]. Oncogene 2012
127
23


Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.
Keith S Hoek, Natalie C Schlegel, Patricia Brafford, Antje Sucker, Selma Ugurel, Rajiv Kumar, Barbara L Weber, Katherine L Nathanson, David J Phillips, Meenhard Herlyn,[...]. Pigment Cell Res 2006
363
22

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
Paola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, Maike Effern, Amy Kenyon, Christopher J Kershaw, Robert Siddaway, Richard Lisle, Rasmus Freter, Matthew J Daniels,[...]. Genes Dev 2017
136
21

Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Y Cheli, S Giuliano, T Botton, S Rocchi, V Hofman, P Hofman, P Bahadoran, C Bertolotto, R Ballotti. Oncogene 2011
156
21

Toward Minimal Residual Disease-Directed Therapy in Melanoma.
Florian Rambow, Aljosja Rogiers, Oskar Marin-Bejar, Sara Aibar, Julia Femel, Michael Dewaele, Panagiotis Karras, Daniel Brown, Young Hwan Chang, Maria Debiec-Rychter,[...]. Cell 2018
241
21

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.
Jennifer Tsoi, Lidia Robert, Kim Paraiso, Carlos Galvan, Katherine M Sheu, Johnson Lay, Deborah J L Wong, Mohammad Atefi, Roksana Shirazi, Xiaoyan Wang,[...]. Cancer Cell 2018
265
20

Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.
Suzanne Carreira, Jane Goodall, Isil Aksan, S Anna La Rocca, Marie-Dominique Galibert, Laurence Denat, Lionel Larue, Colin R Goding. Nature 2005
279
20

Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
T Strub, S Giuliano, T Ye, C Bonet, C Keime, D Kobi, S Le Gras, M Cormont, R Ballotti, C Bertolotto,[...]. Oncogene 2011
164
18

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.
Florian Rambow, Jean-Christophe Marine, Colin R Goding. Genes Dev 2019
90
20

MITF: master regulator of melanocyte development and melanoma oncogene.
Carmit Levy, Mehdi Khaled, David E Fisher. Trends Mol Med 2006
718
17


Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Jane Goodall, Suzanne Carreira, Laurence Denat, Dominique Kobi, Irwin Davidson, Paolo Nuciforo, Richard A Sturm, Lionel Larue, Colin R Goding. Cancer Res 2008
131
16

MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
Stefanie Riesenberg, Angela Groetchen, Robert Siddaway, Tobias Bald, Julia Reinhardt, Denise Smorra, Judith Kohlmeyer, Marcel Renn, Bengt Phung, Pia Aymans,[...]. Nat Commun 2015
117
16

Fifteen-year quest for microphthalmia-associated transcription factor target genes.
Yann Cheli, Mickael Ohanna, Robert Ballotti, Corine Bertolotto. Pigment Cell Melanoma Res 2010
223
16

Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.
Rizwan Haq, Jonathan Shoag, Pedro Andreu-Perez, Satoru Yokoyama, Hannah Edelman, Glenn C Rowe, Dennie T Frederick, Aeron D Hurley, Abhinav Nellore, Andrew L Kung,[...]. Cancer Cell 2013
548
15

MITF in melanoma: mechanisms behind its expression and activity.
Mariusz L Hartman, Malgorzata Czyz. Cell Mol Life Sci 2015
149
14

Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination.
Sophie Pinner, Peter Jordan, Kirsty Sharrock, Laura Bazley, Lucy Collinson, Richard Marais, Elise Bonvin, Colin Goding, Erik Sahai. Cancer Res 2009
149
13

Melanocytes and the microphthalmia transcription factor network.
Eiríkur Steingrímsson, Neal G Copeland, Nancy A Jenkins. Annu Rev Genet 2004
524
13

A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
Julie Caramel, Eftychios Papadogeorgakis, Louise Hill, Gareth J Browne, Geoffrey Richard, Anne Wierinckx, Gerald Saldanha, Joy Osborne, Peter Hutchinson, Gina Tse,[...]. Cancer Cell 2013
325
13

Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
Patrick Laurette, Thomas Strub, Dana Koludrovic, Céline Keime, Stéphanie Le Gras, Hannah Seberg, Eric Van Otterloo, Hana Imrichova, Robert Siddaway, Stein Aerts,[...]. Elife 2015
97
13

MITF controls the TCA cycle to modulate the melanoma hypoxia response.
Pakavarin Louphrasitthiphol, Ioanna Ledaki, Jagat Chauhan, Paola Falletta, Robert Siddaway, Francesca M Buffa, David R Mole, Tomoyoshi Soga, Colin R Goding. Pigment Cell Melanoma Res 2019
24
54

Phenotype plasticity as enabler of melanoma progression and therapy resistance.
Imanol Arozarena, Claudia Wellbrock. Nat Rev Cancer 2019
126
13

Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
Jinyan Du, Hans R Widlund, Martin A Horstmann, Sridhar Ramaswamy, Ken Ross, Wade E Huber, Emi K Nishimura, Todd R Golub, David E Fisher. Cancer Cell 2004
287
12

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Alexander Roesch, Mizuho Fukunaga-Kalabis, Elizabeth C Schmidt, Susan E Zabierowski, Patricia A Brafford, Adina Vultur, Devraj Basu, Phyllis Gimotty, Thomas Vogt, Meenhard Herlyn. Cell 2010
807
12

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
Gaël G McGill, Martin Horstmann, Hans R Widlund, Jinyan Du, Gabriela Motyckova, Emi K Nishimura, Yi-Ling Lin, Sridhar Ramaswamy, William Avery, Han-Fei Ding,[...]. Cell 2002
534
12

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.
Michael P Smith, Holly Brunton, Emily J Rowling, Jennifer Ferguson, Imanol Arozarena, Zsofia Miskolczi, Jessica L Lee, Maria R Girotti, Richard Marais, Mitchell P Levesque,[...]. Cancer Cell 2016
140
12

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation.
Jennifer Landsberg, Judith Kohlmeyer, Marcel Renn, Tobias Bald, Meri Rogava, Mira Cron, Martina Fatho, Volker Lennerz, Thomas Wölfel, Michael Hölzel,[...]. Nature 2012
358
12

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
12

Microenvironment-derived factors driving metastatic plasticity in melanoma.
Isabella S Kim, Silja Heilmann, Emily R Kansler, Yan Zhang, Milena Zimmer, Kajan Ratnakumar, Robert L Bowman, Theresa Simon-Vermot, Myles Fennell, Ralph Garippa,[...]. Nat Commun 2017
87
12

Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.
Erez Feige, Satoru Yokoyama, Carmit Levy, Mehdi Khaled, Vivien Igras, Richard J Lin, Stephen Lee, Hans R Widlund, Scott R Granter, Andrew L Kung,[...]. Proc Natl Acad Sci U S A 2011
86
12

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.
Chong Sun, Liqin Wang, Sidong Huang, Guus J J E Heynen, Anirudh Prahallad, Caroline Robert, John Haanen, Christian Blank, Jelle Wesseling, Stefan M Willems,[...]. Nature 2014
526
11

New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.
Florian Rambow, Bastien Job, Valérie Petit, Franck Gesbert, Véronique Delmas, Hannah Seberg, Guillaume Meurice, Eric Van Otterloo, Philippe Dessen, Caroline Robert,[...]. Cell Rep 2015
48
22

Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
Sandy Giuliano, Yann Cheli, Mickaël Ohanna, Caroline Bonet, Laurent Beuret, Karine Bille, Agnès Loubat, Véronique Hofman, Paul Hofman, Gilles Ponzio,[...]. Cancer Res 2010
94
11

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
331
11


MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.
Diego Ploper, Vincent F Taelman, Lidia Robert, Brian S Perez, Björn Titz, Hsiao-Wang Chen, Thomas G Graeber, Erika von Euw, Antoni Ribas, Edward M De Robertis. Proc Natl Acad Sci U S A 2015
144
11

STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
11

Novel MITF targets identified using a two-step DNA microarray strategy.
Keith S Hoek, Natalie C Schlegel, Ossia M Eichhoff, Daniel S Widmer, Christian Praetorius, Steingrimur O Einarsson, Sigridur Valgeirsdottir, Kristin Bergsteinsdottir, Alexander Schepsky, Reinhard Dummer,[...]. Pigment Cell Melanoma Res 2008
172
11


Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth.
Jennifer Ferguson, Michael Smith, Isabel Zudaire, Claudia Wellbrock, Imanol Arozarena. Oncotarget 2017
31
32

A landscape of driver mutations in melanoma.
Eran Hodis, Ian R Watson, Gregory V Kryukov, Stefan T Arold, Marcin Imielinski, Jean-Philippe Theurillat, Elizabeth Nickerson, Daniel Auclair, Liren Li, Chelsea Place,[...]. Cell 2012
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.